Avigya Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.60 Cr
as on 06-11-2024
- Paid Up Capital ₹ 1.60 Cr
as on 06-11-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.50 M
as on 06-11-2024
- Revenue 81.57%
(FY 2023)
- Profit 7.41%
(FY 2023)
- Ebitda -13.52%
(FY 2023)
- Net Worth 275.33%
(FY 2023)
- Total Assets 12.05%
(FY 2023)
About Avigya Biosciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.60 Cr and a paid-up capital of Rs 1.60 Cr.
The company currently has active open charges totaling ₹7.50 M.
Ramakrishna Kamutam, Ravindar Kotla, Radhika Gandam, and One other member serve as directors at the Company.
- CIN/LLPIN
U36999TG2020PTC140818
- Company No.
140818
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Avigya Biosciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramakrishna Kamutam  | Director | 13-Jun-2020 | Current |
| Ravindar Kotla | Director | 13-Jun-2020 | Current |
| Radhika Gandam | Director | 11-Oct-2020 | Current |
| Mangalapally Jyothi | Director | 25-Feb-2021 | Current |
Financial Performance of Avigya Biosciences.
Avigya Biosciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 81.57% increase. The company also saw a slight improvement in profitability, with a 7.41% increase in profit. The company's net worth Soared by an impressive increase of 275.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avigya Biosciences?
Unlock access to Avigya Biosciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 01 Dec 2022 | ₹7.50 M | Open |
How Many Employees Work at Avigya Biosciences?
Avigya Biosciences has a workforce of 14 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avigya Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avigya Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
